DecisionDx-UM
Commercial- Indications
- Uveal melanoma
Company intelligence / Profile preview
Castle Clinical
Friendswood, Texas, USAcastlebiosciences.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Castle Biosciences offers innovative diagnostic tests that guide patient care by providing personalized risk assessments for various cancers and conditions. Their tests, such as DecisionDx-Melanoma and TissueCypher for Barrett’s Esophagus, have shown significant clinical utility in improving patient outcomes.
- Therapeutic areas
- OncologyGastroenterology
- Modalities
- Gene Expression Profiling (GEP)Biomarker Analysis
- Industry
- Molecular Diagnostics
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
SciBase (for diagnostic test development)
Beyond the preview
Go deeper on Castle Clinical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Castle Clinical.